Use Of Specialty Drug Tiers Jumps Among Employer Plans In 2013, Survey Finds
This article was originally published in The Pink Sheet Daily
The increase in the number of employer plans with four or more formulary tiers in 2013 is notable because the percentage remained in the 13% to 14% range for the past three years, according to figures from an annual survey by the Kaiser Family Foundation and the Health Research and Educational Trust.
You may also be interested in...
Senate Finance confirmation hearing concluded without a vote on Xavier Becerra’s nomination as Health and Human Services Department secretary. Republicans continued to express concerns with his background and views. But he is expected to win enough votes to clear the committee.
‘We need the pharmaceutical industry … to always feel we’ve got their back to innovate,’ Becerra tells Senate Committee. ‘But we have to ensure that we’re getting our dollars’ worth.’
Chiquita Brooks-LaSure would be in a key position to implement the Biden Administration’s drug pricing priorities and is familiar with the balancing act needed when considering competing interests among stakeholders as policies are shaped.